cmv-vst
Cell therapyexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Apr 15, 2025 (NCT07015801)
Timeline
No events for the selected filters.
Mechanism of action
- CytomegalovirusImmunity, passive
Cytomegalovirus immunity, passive
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07015801 | N/A | Apr 15, 2025 | Alberta Precision Laboratories, University of Alberta, University of Calgary |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Alberta Precision Laboratories | For profit | 1 | 0 | 1 | 2025 |
| University of Alberta | Academic/Hospital | 1 | 0 | 1 | 2025 |
| University of Calgary | Academic/Hospital | 1 | 1 | 1 | 2025 |
3 organizations
Page 1 / 1